ZYBERNO
Stock Report
Updated Aug 26, 2026

INNOVATIVE EYEWEAR, INC. (LUCYW)

Healthcare • NASDAQ

$0.04

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
17.0/100
POOR BUSINESS
INNOVATIVE EYEWEAR, INC. (LUCYW) scores 17/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-88.9%)
Debt-to-Equity (Solvency Risk):POOR (1.86x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (0.0%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

INNOVATIVE EYEWEAR, INC. (LUCYW) stock report — Zyberno Score 17/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, LUCYW generated -$7.32M in Owner Earnings. Capital was deployed as follows: $72.51K invested in capital expenditures.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.04
Market Cap:$276.71K

Valuation Multiples (3)

P/B Ratio:0.04x
P/S Ratio:0.08x
Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$4.41M
Ev Ebitda Ratio:23.58x

Price Action & Momentum (3)

Momentum Percentile:19 / 100
% of 52-Week High:23.9%
B. Profitability Assessment

Margin Analysis (2)

Net Margin Ttm:-225.3%
Ebitda Margin:5.5%

TTM Performance (2)

Gross Margin Ttm:22.8%
Net Margin Ttm:-225.3%

Yield Metrics (2)

Earnings Yield:-$2.66K
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):61.1%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:12.06x
Quick Ratio:8.91x
Cash Ratio:4.36x

Leverage Analysis (3)

Debt To Equity Ttm:1.86x
Debt-to-Equity Ratio:1.86x
Debt To Ebitda:35.22x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:6,222,907.00
Cash And Cash Equivalents:2,455,146.00
Long Term Debt:$6.09M
Net Debt:$4.13M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $3.41M
Linear Growth: 61.1%
📊 Click to view full LUCYW Revenue analysis & methodology →
Cost Of Revenue Ttm:$2.63M

Profitability Breakdown (2)

Gross profit TTM: $777.54K
Linear Growth: 97.3%
📊 Click to view full LUCYW Gross Profit analysis & methodology →
$0.00

Bottom Line Performance (3)

-$7.69M
Income Before Tax:$0.00
Ebitda Ttm:187,092.00

Operating Expenses (5)

Operating Expenses:9,274,368.00
R And D Expense:526,790.00
Sga Expense:5,632,241.00
Income Tax Expense:$0.00
Interest Expense:0.00

Expense Ratios (3)

R And D To Revenue Percentage:52.1%
Sga To Revenue Percentage:557.4%
Ebitda Margin:5.5%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$7.47M
Current Assets:$6.79M
Ppe Net:308,606.00
Goodwill:0.00
Intangible Assets:$627.93K

Liability Structure (4)

Total Liabilities:574,385.00
Current Liabilities:562,726.00
Long Term Debt:$6.09M
Short Term Debt:$497.49K

Equity & Capital (3)

Equity:$6.90M
Retained Earnings:-$36.31M
Common Stock:50,000,000.00

Working Capital Items (3)

Accounts Receivable:136,402.00
Inventory:1,772,410.00
Accounts Payable:497,489.00

Special Items (2)

Contract Liabilities:19,871.00
Stock Based Compensation:200,992.00
C. Cash Flow Analysis

Operating Activities (2)

-$7.45M-$7.53M

Investment Activities (2)

Investing Cash Flow:-$1.05M
Capital Expenditures Ttm:72,513.00

Financing Activities (3)

Financing Cash Flow:$1.40M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:1,500,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:187,092.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-1.15
-$1.15
Earnings Per Share Ttm:-$1.20

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.53
Operating Cash Flow Per Share:-$1.14

Book Value & Capital (2)

Book Value Per Share:$1.08
Cash Per Share:0.38

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.36x
Working Capital Turnover Ttm:0.55x

Receivables Management (2)

Receivables Turnover Ttm:25.01x
Days Sales Outstanding Ttm:14.59

Inventory Management (2)

Inventory Turnover Ttm:1.49x
Days Inventory Outstanding Ttm:245.56

Payables & Cash Cycle (2)

Days Payable Outstanding:68.93
Cash Conversion Cycle:191.23
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:40.00
Quality Score:25.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$7.32M
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):61.1%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):97.3%
Book Value Growth Rate (Linear):14.1%
C. Company Profile & Context

Corporate Information (6)

Symbol:LUCYW
Company Name:INNOVATIVE EYEWEAR, INC.
Sector:Healthcare
Industry:Ophthalmic Goods
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:6.41M
Shares Outstanding Basic:6.41M
Shares Outstanding Diluted:6.41M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-26 09:46:38 UTC
Data Timestamp:2026-08-26T09:46:38.530868
Scroll to Top